M&A Deal Summary |
|
---|---|
Date | 2024-05-22 |
Target | Biopas |
Sector | Life Science |
Buyer(s) | Swixx Biopharma |
Sellers(s) | Darby Overseas Investments |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Swixx BioPharma is a specialized distributor of rare diseases, Rx and OTC medicinal products in Central & Eastern Europe, and acts as a true commercialization partner for Biotech & Pharma companies in this area. Swixx Biopharma was founded in 2014 and is based in Baar, Switzerland.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Colombia) | 1 of 1 |
Year (2024) | 1 of 1 |
Category | Private Equity Firm |
---|---|
Founded | 1994 |
Size | Large |
Type | Sector Agnostic |
Darby Overseas Investments is an emerging markets investment firm that sponsors and manages private equity, mezzanine finance, and fixed-income funds for institutional investors and high-net-worth individuals. Darby targets investments in Latin/South America, Asia, and Europe. Sectors of interest include consumer products, specialty retail, distribution, packaging, hotel management, energy, financial services, media and publishing. Darby was formed in 1994 and is based in Washington DC.
DEAL STATS | # |
---|---|
Overall | 10 of 10 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 5 of 5 |
Country (Colombia) | 1 of 1 |
Year (2024) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-02-12 |
Biopas
Bogotá, Colombia Biopas is an independent marketing and distribution company serving international biopharmaceutical firms that focuses on carving out strong market positions for exclusive products. Biopas was founded in 2002 and is based in Bogotá, Colombia. |
Buy | - |